摘要
目的探讨血管紧张素转换酶基因(ACE)I/D位点基因多态性与偏头痛易感性之间的关系。方法通过检索PubMed和EMBASE数据库收集已发表的有关ACE I/D基因多态性与偏头痛易感性关系的病例对照研究,通过固定效应模型或随机效应模型合并效应量OR和95%CI以评价ACE I/D多态性与偏头痛易感性的关联性,同时进行种族及偏头痛类型亚组分析。结果 Meta分析中纯合子模型(DDvs.II:OR=1.21,95%CI:1.02~1.44,P=0.03;I2=47%)和显性模型(DD+DI vs.II:OR=1.16,95%CI:1.01~1.33,P=0.04;I2=50%)均提示ACE I/D多态性与所有偏头痛的易感性呈正相关。杂合子模型和显性模型提示ACE I/D多态性显著增加有先兆偏头痛的易感性。结论 ACE基因I/D位点多态性与偏头痛易感性相关,其D等位基因是偏头痛的危险因素,特别是显著增加有先兆偏头痛的易感性。
Objective To investigate the association between the angiotensin-converting enzyme(ACE)I/D locus polymorphism and migraine susceptibility.Methods The case control studies on the relation between ACE I/D gene polymorphism and migraine susceptibility published in the databases of PubMed and EMBAE were retrieved.The relationship between ACE 1/D polymorphism and migraine was evaluated through the effect size(OR)and 95% confidence interval(CI)by fixed-effects model or random-effect models.Meanwhile the subgroup analysis of ethnicity and migraine types was performed.Results In meta analysis,the homozygote model(DDvs.II:OR=1.21,95%CI:1.02-1.44,P=0.03;I2=47%)and dominant model all indicated that the ACE I/D polymorphism was positively correlated with the susceptibility of all migraine.The heterozygote model(DI vs.II:OR=1.35,95%CI:1.06-1.72,P=0.02;I2=10%)and dominant model(DD+DI vs.II:OR=1.37,95%CI:1.09-1.73,P=0.00;I2=40%)indicated that ACE I/D polymorphism significantly increased the susceptibility of migraine with aura.Conclusion The ACE I/D locus polymorphism is correlated with migraine susceptibility,its D allele is a risk factor of migraine,which especially increases the susceptibility of migraine with aura.
引文
[1]Haut SR,Bigal ME,Lipton RB.Chronic disorders with episodic manifestations:focus on epilepsy and migraine[J].Lancet Neurol,2006,5(2):148-157.
[2]Wessman M,Terwindt GM,Kaunisto MA,et al.Migraine:a complex genetic disorder[J].Lancet Neurol,2007,6(6):521-532.
[3]Headache Classification Subcommittee of the International Headache Society.The international classification of headache disorders:2nd edition[J].Cephalalgia,2004,24Suppl 1(12):9-160.
[4]Moskowitz MA.The neurobiology of vascular head pain[J].Ann Neurol,1984,16:157-168.
[5]Pietrobon D,Striessnig J.Neurobiology of migraine[J].Nat Rev Neurosci,2003,4(5):386-398.
[6]Tietjen EG.Migraine and ischaemic heart disease and stroke:potential mechanisms and treatmentimplications[J].Cephalalgia,2007,27(8):981-987.
[7]Schrader H,Stovner LJ,Helde G,et al.Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor(lisinopril):randomized,placebo controlled crossover study[J].BMJ,2001,322(7277):19-22.
[8]Rigat B,Hubert C,Alhenc-Gelas F,et al.An insertion/deletion polymorphism in the antiotension-converting enzyme gene accounts for half the variance of serum enzyme levels[J].J Clin Invest,1990,86(4):1343-1346.
[9]Mantel N,Haenszel W.Statistical aspects of the analysis of data from retrospective studies of disease[J].J Natl Cancer Inst,1959,22(4):719-748.
[10]DerSimonian R,Laird N.Meta-analysis in clinical trials[J].Control Clin Trials,1986,7(3):177-188.
[11]Paterna S,Di Pasquale P,D′Angelo A,et al.Angiotensinconverting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura[J].Eur Neurol,2000,43(3):133-136.
[12]Cakmak EA,Cataloluk O,Yoldas T,et al.Migraine and angiotensin-converting enzyme association in Turkish patients[J].Pain Clinic,2003,15(4):473-477.
[13]Lin JJ,Wang PJ,Chen CH,et al.Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man[J].Acta Neurol Taiwan,2005,14(3):120-125.
[14]Kowa H,Fusayasu E,Ijiri T,et al.Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura[J].Neurosci Lett,2005,374(2):129-131.
[15]Lea RA,Ovcaric M,Sundholm J,et al.Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility[J].Brain Res Mol Brain Res,2005,136(1/2):112-117.
[16]Kara I,Ozkok E,Aydin M,et al.Combined effects of ACE and MMP-3polymorphisms on migraine development[J].Cephalalgia,2007(3),27:235-243.
[17]Tronvik E,Stovner LJ,Bovim G,et al.Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients[J].BMC Neurol,2008,8(1):1-5.
[18]Joshi G,Pradhan S,Mittal B.Role of the ACE ID and MTHFR C677Tpolymorphisms in genetic susceptibility of migraine in a north Indian population[J].J Neurol Sci,2009,277(1/2):133-137.
[19]Horasanli B,Atac FB,Coven I,et al.Angiotensin I-converting enzyme gene(I/D)polymorphism in patients with migraine[J].Headache,2013,53(1):161-164.
[20]An XK,Lu CX,Ma QL,et al.Association of MTHFR C677Tpolymorphism with susceptibility to migraine in the Chinese population[J].Neurosci Lett,2013,549(33):78-81.
[21]Palmirotta R,Barbanti P,Ludovici G,et al.Association between migraine and ACE gene(insertion/deletion)polymorphism:the BioBIMstudy[J].Pharmacogenomics,2014,15(2):147-155.
[22]Fusayasu E,Kowa H,Takeshima T,et al.Increased plasma substance P and CGRP levels,and high ACE activity in migraineurs during headache-free periods[J].Pain2007,128(3):209-214.
[23]Schurks M,Rist PM,Kurth T.MTHFR 677C>T and ACE D/I Polymorphisms in Migraine:a Systematic Review and Meta-Analysis[J].Headache,2010,50(4):588-599.
